Evaluación de la enfermedad de membrana hialina en recien nacidos

Autores:: Perna, Juan Augusto
Pérez H., Iván
Ramírez, Julia Eugenia
Varela D, Maŕia Elena

Tipo de recurso:: Article of journal

Fecha de publicación:: 2002

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_9461ce96398ef00fe70d02023bda24e5
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2187
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Evaluación de la enfermedad de membrana hialina en recien nacidos
dc.title.translated.eng.fl_str_mv	Evaluation of hyaline membrane disease in newborns
title	Evaluación de la enfermedad de membrana hialina en recien nacidos
spellingShingle	Evaluación de la enfermedad de membrana hialina en recien nacidos Síndrome de distres respiratorio del recien nacido enfermedad de membrana hialina surfactante pulmonar cuidado intensivo neonatal prematuro Newborn respiratory distress syndrome hyaline membrane disease pulmonary surfactant neonatal intensive care premature
title_short	Evaluación de la enfermedad de membrana hialina en recien nacidos
title_full	Evaluación de la enfermedad de membrana hialina en recien nacidos
title_fullStr	Evaluación de la enfermedad de membrana hialina en recien nacidos
title_full_unstemmed	Evaluación de la enfermedad de membrana hialina en recien nacidos
title_sort	Evaluación de la enfermedad de membrana hialina en recien nacidos
dc.creator.fl_str_mv	Perna, Juan Augusto Pérez H., Iván Ramírez, Julia Eugenia Varela D, Maŕia Elena
dc.contributor.author.spa.fl_str_mv	Perna, Juan Augusto Pérez H., Iván Ramírez, Julia Eugenia Varela D, Maŕia Elena
dc.subject.spa.fl_str_mv	Síndrome de distres respiratorio del recien nacido enfermedad de membrana hialina surfactante pulmonar cuidado intensivo neonatal prematuro
topic	Síndrome de distres respiratorio del recien nacido enfermedad de membrana hialina surfactante pulmonar cuidado intensivo neonatal prematuro Newborn respiratory distress syndrome hyaline membrane disease pulmonary surfactant neonatal intensive care premature
dc.subject.eng.fl_str_mv	Newborn respiratory distress syndrome hyaline membrane disease pulmonary surfactant neonatal intensive care premature
publishDate	2002
dc.date.accessioned.none.fl_str_mv	2002-06-01 00:00:00 2022-02-21T20:34:59Z
dc.date.issued.none.fl_str_mv	2002-06-01
dc.date.available.none.fl_str_mv	2002-06-01 00:00:00 2022-02-21T20:34:59Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.v11.n2.2002.277
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2187
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.v11.n2.2002.277
identifier_str_mv	10.31260/RepertMedCir.v11.n2.2002.277 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2187 https://doi.org/10.31260/RepertMedCir.v11.n2.2002.277
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Correa J, Pifieros JG, Gómez A y col. Síndrome de Dificultad Respiratoria del Recién Nacido. UCIN 2000;1: 22-9. Taeusch W, Ballard R. Avery's Diseases of the Newborn. Séptima Edición, W.B. Saunders Company 1998. Pág: 602- 612. Fanaroff A, Martin R, y col. Neonatal. Perinatal Medicine, Sexta Edición, Editorial Mosby, 1998: 1018-29. Hack M, Very low birthweight outcomes of the NICHD neonatal network November 1989 - October 1990, Am J Obst Gynecol 172:457. Taussing, Linn M, Landau Louis, Pediatric Respiratory Medicine, 1999. Editorial Mosby. Primera Edición. Páginas 464- 468. Tapia J, Ventura P, Manual de Neonatología. Segunda Edición. Editorial Mediterráneo. 2000. Capítulo 27, Páginas 244-247. Lee K, Khoshnood B, Wall S. Trend in mortality from respiratory distrés syndrome in the Unites States, 1.970-1.995. J Ped 1999; 134: 4. Ranganathan D, Wall S y col. Racial differences in respiratory-related neonatal mortality among very low birth weight infants. J Ped 2000;136: 4. Abbasi S, Hirsch D, Davis J. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am Jr of Obstetrics and Gynecology 2000; 182: 5. Van Golde LMG, The pulmonary surfactant system: biochemical aspects and functional significance, Physiol Rew 1988, 68:374. Kattwinkel J, Bloom B, Delmore P. High-versus low trheshold surfactant retreatment for neonatal Respiratory Distrés Syndrome. Pediatrics 2000; 106: 2. Hallman M, Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol 1976; 125:613. Hallman M, Role of myo-inositol in the synthesis of phosphatidylglycerol and phosphatidylinositol in the lung: Biochem Biophys Res Commun 1980; 92:1151. Ikegami M, Surfactant protein A metabolism in preterm vetiled lambs, Am J Physiol 1992; 262:765. Weaver TE, Function and regulation of expression of pulmonary surfactant-associated proteins, Biochem Jr 1991; 273:249. McNeely TB, Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages, J lnfect Dis 1993; 167:91. O'Brodovich H, Bicarbonate concentration in rhesus monkey and guinea pig fetal lung fluid, Am Rev Respir Dis 1992; 146:1613. Possmayer F: The role of surfactant-associated proteins, Am Rev Respir Dis 1990;142:749. Hamvas A, Surfactant protein B deficiency: antenatal diag- nosis and prospective treatment with surfactant replacement, J Pediatr 1994;125:356. DeMello DE, Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr 1994; 125:43. Clements JA, Kinetics of surface active material in fetal lung. In Hodson WA, editor: Development of the lung, New York, 1977; 543-544. Gluck L, The interpretation and significance of the lecithin/ sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol 1974; 120:142. Kulovich MV, The lung profile. Am J Obstet Gynecol 1979; 135:57. Pryhuber GS, Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity, Ped Res 1991; 30:597. Jobe AH, et al: Surfactant for the treatment of respiratory distress syndrome, Am Rev Respir Dis 1987; 136:1256. Hallman M, Surfactant protein A , phosphatidylcoline, and surfactant, inhibitors in epithelial lining fluid. Am Rev Resp Dis 1994; 144:1376. Glatz T, Metabolism of exogenously administered natural surfactant in newborn lambs, Pediatr Res 1982; 16:711. Garland J, Alex C, Pauly T y col. A three day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates. Pediatrics 1999; 104: 1. Sinkin R, Dweck H, Horgan M y col. Early dexamethason attempting to prevent chronic lung disease. Pediatrcis 2000; 105: 3. American Academy or Pediatrics. Surfactant replacement therapy for Respiratory Distrés Syndrome. Pediatrics 1999; 103: 3. Jobe HA, et al:Catabolism and recycling of surfactant: In Robertson B, et al , editors: The pulmonary surfactant system, Amsterdam, 1992. Newman B. Imaging of medical disease of the newborn lung. Radiologic Clinics of North America 1999; 37: 6. Ablow RC, A comparison of early onset group B streptococal neonatal infection and the respiratory distrés syndrome of the newborn. N Engl J Med 1976; 294:65. Mariani G, Cifuentes J, Carlo W. Randomized trial of permissive hypercapnia in preterm infants. Pediatrics 1999; 104: 5. McEvoy C, Bowling S, Williamson K y col. Timing of antenatal corticosteroids an neonata] pulmonary mechanics. American Journal of Obstetrics and Gynecology 2000; 183:4. Klaus, Marshall, Fanaroff, Avroy: Care of the high- risk neonate. Novena Edición 1993. Fujiwara T, Artificial surfactant therapy in hyaline membrane disease, Lancet 1980; 1:55. Didziulis L, Perna J, Varela M, Martínez L, Mateus M, Campo M y Col, Uso de Eritropoyetina en Pretérminos, Hospital de San José 1998. Hallman M, Exogenous human surfactant for treatment of severe respiratory distrés syndrome: a randomized prospective clinical trial, J Pediatr 1985;106:963. Phibbs RH, Inictial clinical rial of EXOSURF, a proteinfree synthetic surfactant, for he prophylaxis and early treatment of hyaline membrane disease, Pediatrics 1991; 88:1. Clinicas de Perinatologia. Controversias en el cuidado pulmonar neonatal, Editorial McGraw-Hill 1998, Pág 17-35, 85-90,105-122, 195-220. Yamaguchi N, Togari H, Suzuki S. Apparatus and techniques. Critical Care Medicine 2000; 28: 5. Clark R, Slutsky A, Gerstmann D. Lung protective strategies of ventilation in the neonate. Pediatrics 2000; 105: 1. Lemons J, Blackmon L, Danto W y col. Use of Inhaled Nitric Oxide. AAP. Pediatrices 2000; 106: 2. Rimensberger P, Beghetti M, Hanquinet S y col. First intention High-frequency Oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with SDR. Pediatrics 2000; 105: 6. Farrell P, Fiascone J. Bronchopulmonary Dysplasia in the 1990s. Curr Probl Pediatr 1997: 133 - 63. Bancalari E. Comentario sobre la Displasia Broncopulmonar. Neonatología Práctica 1998. Tercera Edición: 246-249. Shenai J, Mellen B, Chytil F. Vitamin A Status and Postnatal Dexamethasone Treatment in Bronchopulmonary Dysplasia. Pediatrics 2000, 1-6; 3. Montenegro M, Amaya L, Retinopatia de la prematurez. Actualizaciones Pediatricas 1998,8; 3:96-100 Volpe J, Neurology of the newborn. Tercera edición. Filadelfia: W.B. Saunders, 1995, cap,11. Cloherty J, Stark A. Manual de Cuidados Neonatales. Tercera edición, Barcelona: Editorial Masson 1999, Cap,6,24,2 Couser R, Neurodevelopmental follow-up at 36 months 's corrected age of preterm infants treated with prophylactic indomethacin. Arc Pediatr Adolesc Med 2000, 154; 6: 598- 602. Angerio A, Kot P. Closure of the ductus arteriosus new insights for critical care. Critical Care Nursing Quarterly 1998, 20; 4: 80-85. Pacifico L, Panero A, Roggini M. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 1997, 16; 579-86.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/277/270
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2002 : Abril – Junio
dc.relation.citationendpage.none.fl_str_mv	20
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationstartpage.none.fl_str_mv	7
dc.relation.citationvolume.spa.fl_str_mv	11
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 2018
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 2018 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/277
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/5795e4b0-4286-4db1-a44d-fce695c522c1/download
bitstream.checksum.fl_str_mv	e754db9ad13928956e1e6897548c4930
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355536227860480
spelling	Perna, Juan Augustob8ca9adb6b9a04efcd7394f1f45430fd300Pérez H., Iván56c5675232c2fb474162a1a76ed73f87300Ramírez, Julia Eugeniac169bd3fb43e6505f7c8f39a5c713af2300Varela D, Maŕia Elenad6dc2684f15089ef735b9dee01f5009c3002002-06-01 00:00:002022-02-21T20:34:59Z2002-06-012002-06-01 00:00:002022-02-21T20:34:59ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 2018info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/277Síndrome de distres respiratorio del recien nacidoenfermedad de membrana hialinasurfactante pulmonarcuidado intensivo neonatalprematuroNewborn respiratory distress syndromehyaline membrane diseasepulmonary surfactantneonatal intensive careprematureEvaluación de la enfermedad de membrana hialina en recien nacidosEvaluation of hyaline membrane disease in newbornsapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v11.n2.2002.2770121-7372https://repositorio.fucsalud.edu.co/handle/001/21872462-991Xhttps://doi.org/10.31260/RepertMedCir.v11.n2.2002.277spaCorrea J, Pifieros JG, Gómez A y col. Síndrome de Dificultad Respiratoria del Recién Nacido. UCIN 2000;1: 22-9.Taeusch W, Ballard R. Avery's Diseases of the Newborn. Séptima Edición, W.B. Saunders Company 1998. Pág: 602- 612.Fanaroff A, Martin R, y col. Neonatal. Perinatal Medicine, Sexta Edición, Editorial Mosby, 1998: 1018-29.Hack M, Very low birthweight outcomes of the NICHD neonatal network November 1989 - October 1990, Am J Obst Gynecol 172:457.Taussing, Linn M, Landau Louis, Pediatric Respiratory Medicine, 1999. Editorial Mosby. Primera Edición. Páginas 464- 468.Tapia J, Ventura P, Manual de Neonatología. Segunda Edición. Editorial Mediterráneo. 2000. Capítulo 27, Páginas 244-247.Lee K, Khoshnood B, Wall S. Trend in mortality from respiratory distrés syndrome in the Unites States, 1.970-1.995. J Ped 1999; 134: 4.Ranganathan D, Wall S y col. Racial differences in respiratory-related neonatal mortality among very low birth weight infants. J Ped 2000;136: 4.Abbasi S, Hirsch D, Davis J. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am Jr of Obstetrics and Gynecology 2000; 182: 5.Van Golde LMG, The pulmonary surfactant system: biochemical aspects and functional significance, Physiol Rew 1988, 68:374.Kattwinkel J, Bloom B, Delmore P. High-versus low trheshold surfactant retreatment for neonatal Respiratory Distrés Syndrome. Pediatrics 2000; 106: 2.Hallman M, Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol 1976; 125:613.Hallman M, Role of myo-inositol in the synthesis of phosphatidylglycerol and phosphatidylinositol in the lung: Biochem Biophys Res Commun 1980; 92:1151.Ikegami M, Surfactant protein A metabolism in preterm vetiled lambs, Am J Physiol 1992; 262:765.Weaver TE, Function and regulation of expression of pulmonary surfactant-associated proteins, Biochem Jr 1991; 273:249.McNeely TB, Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages, J lnfect Dis 1993; 167:91.O'Brodovich H, Bicarbonate concentration in rhesus monkey and guinea pig fetal lung fluid, Am Rev Respir Dis 1992; 146:1613.Possmayer F: The role of surfactant-associated proteins, Am Rev Respir Dis 1990;142:749.Hamvas A, Surfactant protein B deficiency: antenatal diag- nosis and prospective treatment with surfactant replacement, J Pediatr 1994;125:356.DeMello DE, Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr 1994; 125:43.Clements JA, Kinetics of surface active material in fetal lung. In Hodson WA, editor: Development of the lung, New York, 1977; 543-544.Gluck L, The interpretation and significance of the lecithin/ sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol 1974; 120:142.Kulovich MV, The lung profile. Am J Obstet Gynecol 1979; 135:57.Pryhuber GS, Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity, Ped Res 1991; 30:597.Jobe AH, et al: Surfactant for the treatment of respiratory distress syndrome, Am Rev Respir Dis 1987; 136:1256.Hallman M, Surfactant protein A , phosphatidylcoline, and surfactant, inhibitors in epithelial lining fluid. Am Rev Resp Dis 1994; 144:1376.Glatz T, Metabolism of exogenously administered natural surfactant in newborn lambs, Pediatr Res 1982; 16:711.Garland J, Alex C, Pauly T y col. A three day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates. Pediatrics 1999; 104: 1.Sinkin R, Dweck H, Horgan M y col. Early dexamethason attempting to prevent chronic lung disease. Pediatrcis 2000; 105: 3.American Academy or Pediatrics. Surfactant replacement therapy for Respiratory Distrés Syndrome. Pediatrics 1999; 103: 3.Jobe HA, et al:Catabolism and recycling of surfactant: In Robertson B, et al , editors: The pulmonary surfactant system, Amsterdam, 1992.Newman B. Imaging of medical disease of the newborn lung. Radiologic Clinics of North America 1999; 37: 6.Ablow RC, A comparison of early onset group B streptococal neonatal infection and the respiratory distrés syndrome of the newborn. N Engl J Med 1976; 294:65.Mariani G, Cifuentes J, Carlo W. Randomized trial of permissive hypercapnia in preterm infants. Pediatrics 1999; 104: 5.McEvoy C, Bowling S, Williamson K y col. Timing of antenatal corticosteroids an neonata] pulmonary mechanics. American Journal of Obstetrics and Gynecology 2000; 183:4.Klaus, Marshall, Fanaroff, Avroy: Care of the high- risk neonate. Novena Edición 1993.Fujiwara T, Artificial surfactant therapy in hyaline membrane disease, Lancet 1980; 1:55.Didziulis L, Perna J, Varela M, Martínez L, Mateus M, Campo M y Col, Uso de Eritropoyetina en Pretérminos, Hospital de San José 1998.Hallman M, Exogenous human surfactant for treatment of severe respiratory distrés syndrome: a randomized prospective clinical trial, J Pediatr 1985;106:963.Phibbs RH, Inictial clinical rial of EXOSURF, a proteinfree synthetic surfactant, for he prophylaxis and early treatment of hyaline membrane disease, Pediatrics 1991; 88:1.Clinicas de Perinatologia. Controversias en el cuidado pulmonar neonatal, Editorial McGraw-Hill 1998, Pág 17-35, 85-90,105-122, 195-220.Yamaguchi N, Togari H, Suzuki S. Apparatus and techniques. Critical Care Medicine 2000; 28: 5.Clark R, Slutsky A, Gerstmann D. Lung protective strategies of ventilation in the neonate. Pediatrics 2000; 105: 1.Lemons J, Blackmon L, Danto W y col. Use of Inhaled Nitric Oxide. AAP. Pediatrices 2000; 106: 2.Rimensberger P, Beghetti M, Hanquinet S y col. First intention High-frequency Oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with SDR. Pediatrics 2000; 105: 6.Farrell P, Fiascone J. Bronchopulmonary Dysplasia in the 1990s. Curr Probl Pediatr 1997: 133 - 63.Bancalari E. Comentario sobre la Displasia Broncopulmonar. Neonatología Práctica 1998. Tercera Edición: 246-249.Shenai J, Mellen B, Chytil F. Vitamin A Status and Postnatal Dexamethasone Treatment in Bronchopulmonary Dysplasia. Pediatrics 2000, 1-6; 3.Montenegro M, Amaya L, Retinopatia de la prematurez. Actualizaciones Pediatricas 1998,8; 3:96-100Volpe J, Neurology of the newborn. Tercera edición. Filadelfia: W.B. Saunders, 1995, cap,11.Cloherty J, Stark A. Manual de Cuidados Neonatales. Tercera edición, Barcelona: Editorial Masson 1999, Cap,6,24,2Couser R, Neurodevelopmental follow-up at 36 months 's corrected age of preterm infants treated with prophylactic indomethacin. Arc Pediatr Adolesc Med 2000, 154; 6: 598- 602.Angerio A, Kot P. Closure of the ductus arteriosus new insights for critical care. Critical Care Nursing Quarterly 1998, 20; 4: 80-85.Pacifico L, Panero A, Roggini M. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 1997, 16; 579-86.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/277/270Núm. 2 , Año 2002 : Abril – Junio202711Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2509https://repositorio.fucsalud.edu.co/bitstreams/5795e4b0-4286-4db1-a44d-fce695c522c1/downloade754db9ad13928956e1e6897548c4930MD51001/2187oai:repositorio.fucsalud.edu.co:001/21872024-02-02 13:06:25.734https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 2018metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Evaluación de la enfermedad de membrana hialina en recien nacidos

Publicaciones similares